DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

India Glycols Limited — Record Date

NSE 1 hr ago·21 Aug 2026, 1:13 pm

India Glycols

India Glycols Limited has announced the record date of September 2, 2026, for its proposed merger or hive-off. This date is crucial as it determines which shareholders are eligible to receive shares in the resulting entity. To be included, investors must hold the stock in their demat account before the market closes on this day.

This development signals a major corporate restructuring for the company. For investors, it implies a change in the company's structure and ownership. Shareholders of the current entity will transition to the new entity, and the stock will trade under a new ticker symbol. It is a significant event that requires attention to ensure uninterrupted ownership of the new shares.